Vered Bisker-Leib
Chief Executive Officer at COMPASS THERAPEUTICS, INC.
Net worth: 5 M $ as of 2024-04-29
Vered Bisker-Leib active positions
| Companies | Position | Start | End |
|---|---|---|---|
| COMPASS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2016-12-31 | - |
| Director/Board Member | 2024-01-08 | - | |
| Chief Executive Officer | 2024-01-08 | - | |
| Director of Finance/CFO | 2016-12-31 | - | |
| Chief Operating Officer | 2016-12-31 | 2024-01-08 | |
| Investor Relations Contact | 2016-12-31 | - | |
| President | 2020-09-14 | 2024-01-08 | |
| AYALA PHARMACEUTICALS, INC. | Director/Board Member | 2020-07-31 | - |
| Independent Dir/Board Member | 2020-07-31 | - | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
| Chief Operating Officer | 2016-12-31 | - |
Career history of Vered Bisker-Leib
Former positions of Vered Bisker-Leib
| Companies | Position | Start | End |
|---|---|---|---|
| ADVAXIS, INC. | Director/Board Member | 2020-08-17 | 2023-01-18 |
| Independent Dir/Board Member | 2020-08-17 | 2023-01-18 | |
Cydan II, Inc.
 Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2014-10-19 | 2016-10-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2008-05-31 | 2012-12-31 |
| AYALA PHARMACEUTICALS, INC. | Director/Board Member | 2023-01-18 | - |
| IMARA | Founder | - | - |
Olivia Ventures, Inc.
 Olivia Ventures, Inc. Financial ConglomeratesFinance Olivia Ventures, Inc. is a blank check company. It acts as a vehicle to investigate and to pursue a business combination. The company was founded on March 20, 2018 and is headquartered in Boca Raton, FL. | Chief Operating Officer | 2020-06-16 | - |
Training of Vered Bisker-Leib
| University of Massachusetts | Doctorate Degree |
| Technion-Israel Institute of Technology | Undergraduate Degree |
Statistics
International
| United States | 10 |
| Israel | 3 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 3 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| COMPASS THERAPEUTICS, INC. | Health Technology |
| AYALA PHARMACEUTICALS, INC. | Commercial Services |
| Private companies | 6 |
|---|---|
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
Cydan II, Inc.
Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA. | Health Technology |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Imara, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. The company was founded by James Gregg McArthur in 2016 and is headquartered in Brookline, MA. | Health Technology |
Olivia Ventures, Inc.
Olivia Ventures, Inc. Financial ConglomeratesFinance Olivia Ventures, Inc. is a blank check company. It acts as a vehicle to investigate and to pursue a business combination. The company was founded on March 20, 2018 and is headquartered in Boca Raton, FL. | Finance |
Old Ayala, Inc.
 Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Old Ayala, Inc. operates as a clinical-stage oncology company. It focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Rehovot, Israel. | Health Technology |
- Stock Market
- Insiders
- Vered Bisker-Leib
- Experience
